Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB02317"
Predicate | Value (sorted: default) |
---|---|
rdfs:label |
"Alpha-D-Galactose-1-Phosphate"
|
rdf:type | |
drugbank:description |
"
2255-14-3
experimental
This compound belongs to the hexose phosphates. These are carbohydrate derivatives containing an hexose substituted by one or more phosphate groups.
Hexose Phosphates
Organic Compounds
Organooxygen Compounds
Carbohydrates and Carbohydrate Conjugates
Monosaccharides
Monosaccharide Phosphates
Organophosphate Esters
Organic Phosphoric Acids
Oxanes
Secondary Alcohols
1,2-Diols
Primary Alcohols
Ethers
Polyamines
monosaccharide phosphate
oxane
phosphoric acid ester
organic phosphate
secondary alcohol
polyol
1,2-diol
polyamine
primary alcohol
ether
alcohol
logP
-2
ALOGPS
logS
-0.91
ALOGPS
Water Solubility
3.23e+01 g/l
ALOGPS
logP
-3.1
ChemAxon
IUPAC Name
{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phosphonic acid
ChemAxon
Traditional IUPAC Name
[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphosphonic acid
ChemAxon
Molecular Weight
260.1358
ChemAxon
Monoisotopic Weight
260.029718526
ChemAxon
SMILES
OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O
ChemAxon
Molecular Formula
C6H13O9P
ChemAxon
InChI
InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3+,4+,5-,6-/m1/s1
ChemAxon
InChIKey
InChIKey=HXXFSFRBOHSIMQ-FPRJBGLDSA-N
ChemAxon
Polar Surface Area (PSA)
156.91
ChemAxon
Refractivity
46.8
ChemAxon
Polarizability
20.62
ChemAxon
Rotatable Bond Count
3
ChemAxon
H Bond Acceptor Count
8
ChemAxon
H Bond Donor Count
6
ChemAxon
pKa (strongest acidic)
1.16
ChemAxon
pKa (strongest basic)
-3
ChemAxon
Physiological Charge
-2
ChemAxon
Number of Rings
1
ChemAxon
Bioavailability
1
ChemAxon
ChEBI
17973
PubChem Compound
123912
PubChem Substance
46508735
KEGG Compound
C00446
ChemSpider
453
PDB
GL1
SMP00580
GLUT-1 deficiency syndrome
DB01373
Calcium
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
DB03435
Uridine-5'-Diphosphate
DB03685
Uridine-5'-Monophosphate
DB04465
Lactose
P35575
Q16851
P22392
P30085
P07902
P11166
P00709
P15291
Q8WVQ1
P78381
SMP00579
Congenital disorder of glycosylation CDG-IId
DB01373
Calcium
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
DB03435
Uridine-5'-Diphosphate
DB03685
Uridine-5'-Monophosphate
DB04465
Lactose
P35575
Q16851
P22392
P30085
P07902
P11166
P00709
P15291
Q8WVQ1
P78381
SMP00043
Galactose Metabolism
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
DB03435
Uridine-5'-Diphosphate
DB04077
Glycerol
DB04465
Lactose
P06280
P10253
Q53H18
P15121
P51570
P15291
P07902
Q14376
Q16851
P36871
P35575
P19367
P35557
P09848
SMP00496
Galactosemia III
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
P35557
P36871
Q16851
O60701
Q8NBZ7
P07902
P51570
Q14376
SMP00495
Galactosemia II (GALK)
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
P35557
P36871
Q16851
O60701
Q8NBZ7
P07902
P51570
Q14376
SMP00182
Galactosemia
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
DB03435
Uridine-5'-Diphosphate
DB04077
Glycerol
DB04465
Lactose
P06280
P10253
Q53H18
P15121
P51570
P15291
P07902
Q14376
Q16851
P36871
P35575
P19367
P35557
P09848
SMP00444
Lactose Synthesis
DB01373
Calcium
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
DB03435
Uridine-5'-Diphosphate
DB03685
Uridine-5'-Monophosphate
DB04465
Lactose
P35575
Q16851
P22392
P30085
P07902
P11166
P00709
P15291
Q8WVQ1
P78381
SMP00010
Nucleotide Sugars Metabolism
DB01592
Iron
DB01593
Zinc
DB01861
Glucose-Uridine-C1,5'-Diphosphate
DB02317
Alpha-D-Galactose-1-Phosphate
P35557
P36871
Q16851
O60701
Q8NBZ7
P07902
P51570
Q14376
BE0001357
Beta-phosphoglucomutase
Lactococcus lactis subsp. lactis (strain IL1403)
# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284
# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423
unknown
Beta-phosphoglucomutase
Involved in phosphoglucomutase activity
Reversible transformation of glucose 6-phosphate and beta-glucose 1-phosphate
pgmB
Cytoplasmic
None
4.6
24209.0
Lactococcus lactis subsp. lactis (strain IL1403)
GenBank Gene Database
Z70730
GenBank Protein Database
1495997
UniProtKB
P71447
UniProt Accession
PGMB_LACLA
Beta-PGM
EC 5.4.2.6
>Beta-phosphoglucomutase
MFKAVLFDLDGVITDTAEYHFRAWKALAEEIGINGVDRQFNEQLKGVSREDSLQKILDLA
DKKVSAEEFKELAKRKNDNYVKMIQDVSPADVYPGILQLLKDLRSNKIKIALASASKNGP
FLLEKMNLTGYFDAIADPAEVAASKPAPDIFIAAAHAVGVAPSESIGLEDSQAGIQAIKD
SGALPIGVGRPEDLGDDIVIVPDTSYYTLEFLKEVWLQKQK
>666 bp
ATGTTTAAAGCAGTATTGTTTGATTTAGATGGTGTAATTACAGATACCGCAGAGTATCAT
TTTAGAGCTTGGAAAGCTTTGGCTGAAGAAATTGGCATTAATGGTGTTGACCGCCAATTT
AATGAGCAATTAAAAGGGGTCTCACGAGAAGACTCGCTTCAGAAAATTCTAGATTTAGCT
GATAAAAAAGTATCAGCTGAGGAATTTAAAGAACTTGCTAAGAGAAAAAATGATAACTAT
GTGAAAATGATTCAGGATGTGTCGCCAGCCGATGTCTATCCTGGAATTTTACAATTACTC
AAAGATTTACGTTCAAATAAAATCAAAATTGCTTTAGCGTCGGCTTCTAAGAATGGTCCA
TTTTTATTAGAGAGAATGAATTTAACTGGATATTTTGATGCAATTGCTGATCCGGCTGAA
GTTGCAGCATCAAAACCAGCACCAGATATTTTTATTGCAGCAGCACATGCAGTGGGTGTT
GCCCCCTCTGAATCAATTGGGTTAGAGGATTCTCAAGCTGGAATTCAAGCCATCAAAGAT
TCAGGGGCTTTACCAATTGGTGTAGGGCGCCCAGAAGATTTGGGAGATGATATCGTCATT
GTGCCTGATACTTCACACTATACATTAGAATTTTTGAAAGAAGTTTGGCTTCAAAAGCAA
AAATAA
PF00702
Hydrolase
function
hydrolase activity
function
catalytic activity
process
physiological process
process
metabolism
"
|
owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines2/drugbank_small.nt
The resource appears as object in 9 triples